Valmie Resources, Inc. (VMRI) Stock Competitors & Peer Comparison
See (VMRI) competitors and their performances in Stock Market.
Peer Comparison Table: Computer Hardware Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VMRI | $0.00 | +0.00% | 7K | N/A | N/A | N/A |
| QUCCF | $12.25 | +0.00% | 47.2B | 10.21 | $1.20 | +18.07% |
| LNVGY | $63.22 | +5.31% | 38.8B | 22.54 | $2.78 | +1.55% |
| LNVGF | $3.19 | +5.98% | 38.1B | 21.93 | $0.14 | +1.57% |
| CAJFF | $26.36 | -1.91% | 25.5B | 12.82 | $2.29 | +3.63% |
| CAJPY | $27.08 | +0.82% | 23.8B | 11.89 | $2.30 | +3.44% |
| ASUUY | $99.00 | +23.75% | 14.7B | 10.52 | $9.41 | +5.83% |
| SEKEF | $20.20 | +0.00% | 6.5B | 20.00 | $1.01 | +2.39% |
| SEKEY | $8.99 | -0.72% | 5.9B | 50.97 | $0.18 | +2.47% |
| ACEYY | $5.14 | +0.00% | 3.1B | 34.27 | $0.15 | +5.02% |
Stock Comparison
VMRI vs QUCCF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, QUCCF has a market cap of 47.2B. Regarding current trading prices, VMRI is priced at $0.00, while QUCCF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas QUCCF's P/E ratio is 10.21. In terms of profitability, VMRI's ROE is -16.14%, compared to QUCCF's ROE of +0.36%. Regarding short-term risk, VMRI is less volatile compared to QUCCF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check QUCCF's competition here
VMRI vs LNVGY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, LNVGY has a market cap of 38.8B. Regarding current trading prices, VMRI is priced at $0.00, while LNVGY trades at $63.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas LNVGY's P/E ratio is 22.54. In terms of profitability, VMRI's ROE is -16.14%, compared to LNVGY's ROE of +0.27%. Regarding short-term risk, VMRI is less volatile compared to LNVGY. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check LNVGY's competition here
VMRI vs LNVGF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, LNVGF has a market cap of 38.1B. Regarding current trading prices, VMRI is priced at $0.00, while LNVGF trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas LNVGF's P/E ratio is 21.93. In terms of profitability, VMRI's ROE is -16.14%, compared to LNVGF's ROE of +0.27%. Regarding short-term risk, VMRI is less volatile compared to LNVGF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check LNVGF's competition here
VMRI vs CAJFF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CAJFF has a market cap of 25.5B. Regarding current trading prices, VMRI is priced at $0.00, while CAJFF trades at $26.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CAJFF's P/E ratio is 12.82. In terms of profitability, VMRI's ROE is -16.14%, compared to CAJFF's ROE of +0.09%. Regarding short-term risk, VMRI and CAJFF have similar daily volatility (0.00).Check CAJFF's competition here
VMRI vs CAJPY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CAJPY has a market cap of 23.8B. Regarding current trading prices, VMRI is priced at $0.00, while CAJPY trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CAJPY's P/E ratio is 11.89. In terms of profitability, VMRI's ROE is -16.14%, compared to CAJPY's ROE of +0.09%. Regarding short-term risk, VMRI is less volatile compared to CAJPY. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check CAJPY's competition here
VMRI vs ASUUY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, ASUUY has a market cap of 14.7B. Regarding current trading prices, VMRI is priced at $0.00, while ASUUY trades at $99.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas ASUUY's P/E ratio is 10.52. In terms of profitability, VMRI's ROE is -16.14%, compared to ASUUY's ROE of +0.16%. Regarding short-term risk, VMRI and ASUUY have similar daily volatility (0.00).Check ASUUY's competition here
VMRI vs SEKEF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, SEKEF has a market cap of 6.5B. Regarding current trading prices, VMRI is priced at $0.00, while SEKEF trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas SEKEF's P/E ratio is 20.00. In terms of profitability, VMRI's ROE is -16.14%, compared to SEKEF's ROE of +0.03%. Regarding short-term risk, VMRI and SEKEF have similar daily volatility (0.00).Check SEKEF's competition here
VMRI vs SEKEY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, SEKEY has a market cap of 5.9B. Regarding current trading prices, VMRI is priced at $0.00, while SEKEY trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas SEKEY's P/E ratio is 50.97. In terms of profitability, VMRI's ROE is -16.14%, compared to SEKEY's ROE of +0.02%. Regarding short-term risk, VMRI is less volatile compared to SEKEY. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check SEKEY's competition here
VMRI vs ACEYY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, ACEYY has a market cap of 3.1B. Regarding current trading prices, VMRI is priced at $0.00, while ACEYY trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas ACEYY's P/E ratio is 34.27. In terms of profitability, VMRI's ROE is -16.14%, compared to ACEYY's ROE of +0.04%. Regarding short-term risk, VMRI is less volatile compared to ACEYY. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check ACEYY's competition here
VMRI vs LGNRF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, LGNRF has a market cap of 2.7B. Regarding current trading prices, VMRI is priced at $0.00, while LGNRF trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas LGNRF's P/E ratio is -4.52. In terms of profitability, VMRI's ROE is -16.14%, compared to LGNRF's ROE of +0.02%. Regarding short-term risk, VMRI is less volatile compared to LGNRF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check LGNRF's competition here
VMRI vs FXCOF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, FXCOF has a market cap of 2.5B. Regarding current trading prices, VMRI is priced at $0.00, while FXCOF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas FXCOF's P/E ratio is 17.60. In terms of profitability, VMRI's ROE is -16.14%, compared to FXCOF's ROE of +0.03%. Regarding short-term risk, VMRI and FXCOF have similar daily volatility (0.00).Check FXCOF's competition here
VMRI vs DRSHF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, DRSHF has a market cap of 1.9B. Regarding current trading prices, VMRI is priced at $0.00, while DRSHF trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas DRSHF's P/E ratio is 202.00. In terms of profitability, VMRI's ROE is -16.14%, compared to DRSHF's ROE of +0.01%. Regarding short-term risk, VMRI is less volatile compared to DRSHF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check DRSHF's competition here
VMRI vs TSHTY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, TSHTY has a market cap of 1B. Regarding current trading prices, VMRI is priced at $0.00, while TSHTY trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas TSHTY's P/E ratio is -69.54. In terms of profitability, VMRI's ROE is -16.14%, compared to TSHTY's ROE of -0.03%. Regarding short-term risk, VMRI and TSHTY have similar daily volatility (0.00).Check TSHTY's competition here
VMRI vs NLST Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, NLST has a market cap of 918.3M. Regarding current trading prices, VMRI is priced at $0.00, while NLST trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas NLST's P/E ratio is -91.83. In terms of profitability, VMRI's ROE is -16.14%, compared to NLST's ROE of +1.78%. Regarding short-term risk, VMRI is less volatile compared to NLST. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check NLST's competition here
VMRI vs WACMY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, WACMY has a market cap of 639.1M. Regarding current trading prices, VMRI is priced at $0.00, while WACMY trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas WACMY's P/E ratio is 10.80. In terms of profitability, VMRI's ROE is -16.14%, compared to WACMY's ROE of +0.28%. Regarding short-term risk, VMRI and WACMY have similar daily volatility (0.00).Check WACMY's competition here
VMRI vs WACMF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, WACMF has a market cap of 539.5M. Regarding current trading prices, VMRI is priced at $0.00, while WACMF trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas WACMF's P/E ratio is 8.91. In terms of profitability, VMRI's ROE is -16.14%, compared to WACMF's ROE of +0.28%. Regarding short-term risk, VMRI and WACMF have similar daily volatility (0.00).Check WACMF's competition here
VMRI vs PCPPF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, PCPPF has a market cap of 469.2M. Regarding current trading prices, VMRI is priced at $0.00, while PCPPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas PCPPF's P/E ratio is 10.18. In terms of profitability, VMRI's ROE is -16.14%, compared to PCPPF's ROE of +0.16%. Regarding short-term risk, VMRI and PCPPF have similar daily volatility (0.00).Check PCPPF's competition here
VMRI vs JFEYF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, JFEYF has a market cap of 383.7M. Regarding current trading prices, VMRI is priced at $0.00, while JFEYF trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas JFEYF's P/E ratio is 14.37. In terms of profitability, VMRI's ROE is -16.14%, compared to JFEYF's ROE of +0.12%. Regarding short-term risk, VMRI is less volatile compared to JFEYF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check JFEYF's competition here
VMRI vs TAKOF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, TAKOF has a market cap of 303.5M. Regarding current trading prices, VMRI is priced at $0.00, while TAKOF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas TAKOF's P/E ratio is -14.95. In terms of profitability, VMRI's ROE is -16.14%, compared to TAKOF's ROE of -0.44%. Regarding short-term risk, VMRI is less volatile compared to TAKOF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check TAKOF's competition here
VMRI vs AOMUF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, AOMUF has a market cap of 153.8M. Regarding current trading prices, VMRI is priced at $0.00, while AOMUF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas AOMUF's P/E ratio is -10.62. In terms of profitability, VMRI's ROE is -16.14%, compared to AOMUF's ROE of -0.24%. Regarding short-term risk, VMRI and AOMUF have similar daily volatility (0.00).Check AOMUF's competition here
VMRI vs FRIIF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, FRIIF has a market cap of 78.7M. Regarding current trading prices, VMRI is priced at $0.00, while FRIIF trades at $12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas FRIIF's P/E ratio is 6.10. In terms of profitability, VMRI's ROE is -16.14%, compared to FRIIF's ROE of +0.05%. Regarding short-term risk, VMRI and FRIIF have similar daily volatility (0.00).Check FRIIF's competition here
VMRI vs XAARF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, XAARF has a market cap of 76.1M. Regarding current trading prices, VMRI is priced at $0.00, while XAARF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas XAARF's P/E ratio is -5.37. In terms of profitability, VMRI's ROE is -16.14%, compared to XAARF's ROE of -0.06%. Regarding short-term risk, VMRI is less volatile compared to XAARF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check XAARF's competition here
VMRI vs TBIIF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, TBIIF has a market cap of 56.4M. Regarding current trading prices, VMRI is priced at $0.00, while TBIIF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas TBIIF's P/E ratio is -1.71. In terms of profitability, VMRI's ROE is -16.14%, compared to TBIIF's ROE of -0.60%. Regarding short-term risk, VMRI and TBIIF have similar daily volatility (0.00).Check TBIIF's competition here
VMRI vs CREAF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CREAF has a market cap of 54.3M. Regarding current trading prices, VMRI is priced at $0.00, while CREAF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CREAF's P/E ratio is -9.65. In terms of profitability, VMRI's ROE is -16.14%, compared to CREAF's ROE of -0.18%. Regarding short-term risk, VMRI and CREAF have similar daily volatility (0.00).Check CREAF's competition here
VMRI vs JLMKF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, JLMKF has a market cap of 52.1M. Regarding current trading prices, VMRI is priced at $0.00, while JLMKF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas JLMKF's P/E ratio is -8.50. In terms of profitability, VMRI's ROE is -16.14%, compared to JLMKF's ROE of +1.55%. Regarding short-term risk, VMRI is less volatile compared to JLMKF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check JLMKF's competition here
VMRI vs AOTOF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, AOTOF has a market cap of 33.1M. Regarding current trading prices, VMRI is priced at $0.00, while AOTOF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas AOTOF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to AOTOF's ROE of -4.00%. Regarding short-term risk, VMRI and AOTOF have similar daily volatility (0.00).Check AOTOF's competition here
VMRI vs EVRC Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, EVRC has a market cap of 11.4M. Regarding current trading prices, VMRI is priced at $0.00, while EVRC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas EVRC's P/E ratio is 11.67. In terms of profitability, VMRI's ROE is -16.14%, compared to EVRC's ROE of +0.02%. Regarding short-term risk, VMRI and EVRC have similar daily volatility (0.00).Check EVRC's competition here
VMRI vs AITX Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, AITX has a market cap of 11M. Regarding current trading prices, VMRI is priced at $0.00, while AITX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas AITX's P/E ratio is -6.35. In terms of profitability, VMRI's ROE is -16.14%, compared to AITX's ROE of +0.32%. Regarding short-term risk, VMRI is less volatile compared to AITX. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check AITX's competition here
VMRI vs CCUR Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CCUR has a market cap of 6.8M. Regarding current trading prices, VMRI is priced at $0.00, while CCUR trades at $2,310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CCUR's P/E ratio is -4.69. In terms of profitability, VMRI's ROE is -16.14%, compared to CCUR's ROE of +0.22%. Regarding short-term risk, VMRI is less volatile compared to CCUR. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check CCUR's competition here
VMRI vs FNTTF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, FNTTF has a market cap of 4.2M. Regarding current trading prices, VMRI is priced at $0.00, while FNTTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas FNTTF's P/E ratio is -1.37. In terms of profitability, VMRI's ROE is -16.14%, compared to FNTTF's ROE of +0.89%. Regarding short-term risk, VMRI and FNTTF have similar daily volatility (0.00).Check FNTTF's competition here
VMRI vs VRTK Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, VRTK has a market cap of 4M. Regarding current trading prices, VMRI is priced at $0.00, while VRTK trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas VRTK's P/E ratio is 20.50. In terms of profitability, VMRI's ROE is -16.14%, compared to VRTK's ROE of N/A. Regarding short-term risk, VMRI is less volatile compared to VRTK. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check VRTK's competition here
VMRI vs TKSTF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, TKSTF has a market cap of 2M. Regarding current trading prices, VMRI is priced at $0.00, while TKSTF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas TKSTF's P/E ratio is -4.10. In terms of profitability, VMRI's ROE is -16.14%, compared to TKSTF's ROE of +0.06%. Regarding short-term risk, VMRI and TKSTF have similar daily volatility (0.00).Check TKSTF's competition here
VMRI vs CRTG Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CRTG has a market cap of 431.7K. Regarding current trading prices, VMRI is priced at $0.00, while CRTG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CRTG's P/E ratio is -0.15. In terms of profitability, VMRI's ROE is -16.14%, compared to CRTG's ROE of -2.38%. Regarding short-term risk, VMRI and CRTG have similar daily volatility (0.00).Check CRTG's competition here
VMRI vs ITOX Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, ITOX has a market cap of 234.6K. Regarding current trading prices, VMRI is priced at $0.00, while ITOX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas ITOX's P/E ratio is -0.04. In terms of profitability, VMRI's ROE is -16.14%, compared to ITOX's ROE of +0.54%. Regarding short-term risk, VMRI is less volatile compared to ITOX. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check ITOX's competition here
VMRI vs DDDX Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, DDDX has a market cap of 197.6K. Regarding current trading prices, VMRI is priced at $0.00, while DDDX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas DDDX's P/E ratio is -0.50. In terms of profitability, VMRI's ROE is -16.14%, compared to DDDX's ROE of +0.10%. Regarding short-term risk, VMRI is less volatile compared to DDDX. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check DDDX's competition here
VMRI vs HAUP Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, HAUP has a market cap of 104.3K. Regarding current trading prices, VMRI is priced at $0.00, while HAUP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas HAUP's P/E ratio is -0.13. In terms of profitability, VMRI's ROE is -16.14%, compared to HAUP's ROE of +92.50%. Regarding short-term risk, VMRI is less volatile compared to HAUP. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check HAUP's competition here
VMRI vs GOSY Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, GOSY has a market cap of 82.5K. Regarding current trading prices, VMRI is priced at $0.00, while GOSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas GOSY's P/E ratio is -0.10. In terms of profitability, VMRI's ROE is -16.14%, compared to GOSY's ROE of -0.17%. Regarding short-term risk, VMRI and GOSY have similar daily volatility (0.00).Check GOSY's competition here
VMRI vs YRLLF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, YRLLF has a market cap of 54.3K. Regarding current trading prices, VMRI is priced at $0.00, while YRLLF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas YRLLF's P/E ratio is -1.10. In terms of profitability, VMRI's ROE is -16.14%, compared to YRLLF's ROE of +0.08%. Regarding short-term risk, VMRI is less volatile compared to YRLLF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check YRLLF's competition here
VMRI vs EUOT Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, EUOT has a market cap of 48K. Regarding current trading prices, VMRI is priced at $0.00, while EUOT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas EUOT's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to EUOT's ROE of +28.93%. Regarding short-term risk, VMRI is less volatile compared to EUOT. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check EUOT's competition here
VMRI vs RDRSF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, RDRSF has a market cap of 17.7K. Regarding current trading prices, VMRI is priced at $0.00, while RDRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas RDRSF's P/E ratio is -0.01. In terms of profitability, VMRI's ROE is -16.14%, compared to RDRSF's ROE of +2.09%. Regarding short-term risk, VMRI is less volatile compared to RDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check RDRSF's competition here
VMRI vs MDEA Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, MDEA has a market cap of 13.2K. Regarding current trading prices, VMRI is priced at $0.00, while MDEA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas MDEA's P/E ratio is -0.00. In terms of profitability, VMRI's ROE is -16.14%, compared to MDEA's ROE of -1.30%. Regarding short-term risk, VMRI is less volatile compared to MDEA. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check MDEA's competition here
VMRI vs SNIOF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, SNIOF has a market cap of 11.3K. Regarding current trading prices, VMRI is priced at $0.00, while SNIOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas SNIOF's P/E ratio is -0.00. In terms of profitability, VMRI's ROE is -16.14%, compared to SNIOF's ROE of N/A. Regarding short-term risk, VMRI is less volatile compared to SNIOF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check SNIOF's competition here
VMRI vs NADA Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, NADA has a market cap of 9.3K. Regarding current trading prices, VMRI is priced at $0.00, while NADA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas NADA's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to NADA's ROE of -8.82%. Regarding short-term risk, VMRI is less volatile compared to NADA. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check NADA's competition here
VMRI vs VOIS Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, VOIS has a market cap of 8.9K. Regarding current trading prices, VMRI is priced at $0.00, while VOIS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas VOIS's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to VOIS's ROE of +2.41%. Regarding short-term risk, VMRI is less volatile compared to VOIS. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check VOIS's competition here
VMRI vs CBEX Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, CBEX has a market cap of 2.4K. Regarding current trading prices, VMRI is priced at $0.00, while CBEX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas CBEX's P/E ratio is 0.01. In terms of profitability, VMRI's ROE is -16.14%, compared to CBEX's ROE of -0.28%. Regarding short-term risk, VMRI and CBEX have similar daily volatility (0.00).Check CBEX's competition here
VMRI vs MCZAF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, MCZAF has a market cap of 2.2K. Regarding current trading prices, VMRI is priced at $0.00, while MCZAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas MCZAF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to MCZAF's ROE of -1.17%. Regarding short-term risk, VMRI is less volatile compared to MCZAF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check MCZAF's competition here
VMRI vs VIDE Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, VIDE has a market cap of 588. Regarding current trading prices, VMRI is priced at $0.00, while VIDE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas VIDE's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to VIDE's ROE of +0.38%. Regarding short-term risk, VMRI is less volatile compared to VIDE. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check VIDE's competition here
VMRI vs SOSO Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, SOSO has a market cap of 374. Regarding current trading prices, VMRI is priced at $0.00, while SOSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas SOSO's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to SOSO's ROE of -1.25%. Regarding short-term risk, VMRI is less volatile compared to SOSO. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check SOSO's competition here
VMRI vs DWDZF Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, DWDZF has a market cap of 224. Regarding current trading prices, VMRI is priced at $0.00, while DWDZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas DWDZF's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to DWDZF's ROE of +0.66%. Regarding short-term risk, VMRI is less volatile compared to DWDZF. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check DWDZF's competition here
VMRI vs ORYX Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, ORYX has a market cap of 2. Regarding current trading prices, VMRI is priced at $0.00, while ORYX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas ORYX's P/E ratio is -0.00. In terms of profitability, VMRI's ROE is -16.14%, compared to ORYX's ROE of -0.20%. Regarding short-term risk, VMRI and ORYX have similar daily volatility (0.00).Check ORYX's competition here
VMRI vs IWRS Comparison June 2026
VMRI plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMRI stands at 7K. In comparison, IWRS has a market cap of 0. Regarding current trading prices, VMRI is priced at $0.00, while IWRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMRI currently has a P/E ratio of N/A, whereas IWRS's P/E ratio is N/A. In terms of profitability, VMRI's ROE is -16.14%, compared to IWRS's ROE of N/A. Regarding short-term risk, VMRI is less volatile compared to IWRS. This indicates potentially lower risk in terms of short-term price fluctuations for VMRI.Check IWRS's competition here